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While the use of short interfering RNAs (siRNAs) for 
laboratory studies is now common practice, 
development of siRNAs for therapeutic applications 
has slowed, due in part to a still limited 
understanding of the endocytosis and intracellular 
trafficking of siRNA-containing complexes. As a 
result, it is difficult to design delivery vehicles for 
specific cell types, resulting in inefficient delivery, 
cytotoxicity, or immunogenicity when used in vivo. 
Our aim is to identify which endocytosis and 
intracellular trafficking pathways lead to active 
silencing by siRNA-containing complexes. Our work 
explores the preferential mechanism of endocytosis 
(whether by clathrin, caveolin, Arf6, Graf1, flotillin, 
or macropinocytosis) across multiple cell types 
(HeLa (cervical), H1299 (lung), HEK293 (kidney), 
and HepG2 (liver)). 
 
Using Lipofectamine 2000 (LF2K), fluorescently-
labeled siRNAs were delivered to cells stably 
expressing green fluorescent protein (GFP). 
Chemical inhibitors (Filipin, Dynasore, Cytochalasin 
D, Chlorpromazine, Amiloride, and Methyl-β-
cyclodextrin) were used to identify the specific 
endocytic pathway internalizing the complexes. By 
measuring the effect of inhibitors on both 
intracellular levels of siRNA and GFP silencing, we 
were able to categorize pathways as being 
productive/competitive according to their functional 
role in facilitating gene silencing. In productive 
pathways, siRNAs are actively delivered to a cell 
and silence a target protein, whereas in competitive 
pathways, siRNAs are endocytosed but do not lead 
to silencing.  
 
To further validate the findings from our inhibitor 
assay, we overexpressed the following endocytic 
proteins and quantified their effect on siRNA 
uptake: Dynamin, Actin, AP2, Clathrin, Caveolin, 
Flotillin 1, Flotillin 2, Arf6, and Graf1. Together our 
findings suggest that LF2K-siRNA complexes are 
internalized through multiple pathways in all cells 
but that only one of the pathways is productive, 
leading to GFP silencing (Table 1). Interestingly, 
our data suggests that the relative expression of 
endocytic proteins within a cell line may indicate 
which endocytotic pathway is productive. 
Table 1: Productive/competitive pathways utilized 
for LF2K-mediated RNAi. 




HeLa Arf6 Clathrin 
HepG2 Arf6 Clathrin 
H1299 Flotillin Clathrin 
HEK293 Graf1 Arf6 
Additionally, we explored the use of inhibitors in co-
cultured cell populations. Based on our results, we 
were able to selectively inhibit GFP silencing for a 
specific cell line by targeting its productive pathway 
(Figure 1). Furthermore, inhibiting siRNA uptake in 
one targeted cell type enhanced the overall 
bioavailability of siRNA complexes and GFP 
silencing in the other cell population. 
 
Figure 1: Effect of inhibitors on GFP silencing 
between single and co-culture (HeLa and H1299) 
cell populations. 
